Neil Solomons - Mar 2, 2022 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role
Chief Medical Officer
Signature
/s/ Neil Solomons, M.D.
Stock symbol
AUPH
Transactions as of
Mar 2, 2022
Transactions value $
-$58,200
Form type
4
Date filed
3/4/2022, 03:10 PM
Previous filing
Nov 12, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUPH Common Stock Award $0 +8.5K +9.74% $0.00 95.8K Mar 2, 2022 Direct F1
transaction AUPH Common Stock Sale -$58.2K -4.85K -5.06% $12.01 91K Mar 2, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AUPH Restricted Stock Unit Award $0 +72.9K $0.00 72.9K Mar 2, 2022 Common Shares 72.9K Direct F3
transaction AUPH Stock Option (right to buy) Award $0 +125K $0.00 125K Mar 2, 2022 Common Stock 125K $12.01 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 18, 2021, the Reporting Person was granted stock based performance awards ("Performance Awards") which vests when specific performance metrics are met based on the results for the year ended December 31, 2021. It was determined that as of March 2, 2022, the Reporting Person partially met the performance criteria and received shares of common stock for no consideration.
F2 Represents the number of shares sold to cover tax withholding obligations in connection with the vesting of Performance Awards.
F3 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in three (3) equal annual installments beginning March 2, 2022, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date.
F4 One-third of the shares subject to the option vests twelve months from the grant date, and the remainder vests in twenty-four equal monthly installments thereafter.